HR 5416
109th Congress
House
Valley Fever Vaccine Development Act
Official title: To provide for grants to conduct research toward the development of a vaccine against Valley Fever.
Health
Economics and Public FinanceFederal aid to researchFungiPharmaceutical research
More subjectsShow fewer subjects
Research grantsScience, Technology, CommunicationsVaccines
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 5, 2006
Referred to the Subcommittee on Health.
May 18, 2006
Referred to the House Committee on Energy and Commerce.
May 18, 2006
Sponsor introductory remarks on measure. (CR E876-877)
May 18, 2006
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
Valley Fever Vaccine Development Act - Requires the Secretary of Health and Human Resources, acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants for research toward the development of a vaccine against coccidioidomycosis (commonly known as Valley Fever).
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
4
Cite this page
U.S. Congress. (2026). H.R. 5416: Valley Fever Vaccine Development Act. 109th Congress. Open America. https://openamerica.io/bill/109-HR-5416/
"H.R. 5416: Valley Fever Vaccine Development Act." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-5416/.
H.R. 5416, 109th Cong. (2026), https://openamerica.io/bill/109-HR-5416/.
[H.R. 5416: Valley Fever Vaccine Development Act](https://openamerica.io/bill/109-HR-5416/)